Skin & hair

Skin Checks When Your Immune System Is Suppressed

Save

Immunosuppression raises the stakes on skin surveillance, but the right routine is individualized rather than one fixed number. This guide covers who counts as immunosuppressed, how to do a thorough self-skin-exam using the ABCDE signs, how to photograph and track spots between visits, and what the screening evidence does and does not settle.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How often should you get a skin check on immunosuppressants?

There is no single interval that fits everyone. How often you need a professional skin check depends on your specific medicines, how long you have been immunosuppressed, your skin type and sun history, and whether you have had skin cancer before. Your dermatologist or transplant team sets the schedule, and people at higher risk are generally seen more often than the once-in-a-while advice given to the average adult.

What is consistent is the pairing: scheduled professional exams plus your own regular self-checks between them. The professional exam is a full skin examination by a clinician who knows what to look for; the self-check is how most changes are actually caught first, because you see your skin far more often than any doctor does.

The deeper reason immunosuppressed people are watched more closely, and how much the risk climbs, is covered in our companion piece on skin cancer risk after organ transplant and the wider topic of immunosuppression and skin cancer. This page focuses on the how: how to check, how to track, and how to think about timing.

Who counts as immunosuppressed?

Immunosuppression is broader than organ transplant. It includes people on long-term systemic steroids or anti-rejection medicines, some who take immune-suppressing drugs for autoimmune or inflammatory diseases, people on certain cancer treatments, and those with conditions that weaken the immune system. If you are unsure whether your medicines count, your prescriber can tell you, and it is a reasonable question to ask.

Not every immune-modifying medicine carries the same skin-cancer risk, and some targeted therapies differ from broad immunosuppressants. That nuance is exactly why the schedule is individualized rather than universal. What the higher-risk groups share is a reduced ability to clear damaged skin cells, which is why closer skin surveillance is advised.

If you have already been treated for a skin cancer, ongoing monitoring is its own topic, sometimes called skin cancer surveillance, and immunosuppression makes that follow-up more important. The general framework for who should get regular skin checks is a useful orientation, and immunosuppression moves you toward the more frequent end of it.

How to do a self-skin-exam: the ABCDE signs

A self-skin-exam is a systematic look over your whole skin, ideally monthly, using good light, a full-length mirror, and a hand mirror or a helper for hard-to-see areas. The most useful framework for moles is ABCDE: Asymmetry, Border irregularity, Color variation, Diameter larger than a pencil eraser, and Evolving, meaning any change in size, shape, or color over time 1.

The ABCDE signs, one by one:

  • A — Asymmetry: one half does not match the other.
  • B — Border: edges are irregular, scalloped, or poorly defined.
  • C — Color: more than one color, or uneven shades of brown, black, red, white, or blue.
  • D — Diameter: larger than about 6 millimeters, though melanomas can be smaller.
  • E — Evolving: any change in size, shape, or color over weeks to months.

Go beyond moles, too. Check for any sore that will not heal, a spot that itches or bleeds, and a new growth that keeps enlarging. And check the places that get little sun: the soles, palms, between the toes, under the nails, and genital skin. In darker skin, cancers such as acral melanoma on the soles, palms, and nails are easy to miss, which is one reason skin cancer in skin of color is sometimes found later. A genital skin cancer is rare, but a spot on genitals that will not heal deserves the same attention as one anywhere else.

Photograph, track, and what to do if a spot changes

Between checks, the highest-value habit is photographing anything questionable and tracking it over time. Take a clear, well-lit photo with a ruler or coin for scale, note the date, and re-photograph in a few weeks. Comparing dated images turns a vague worry into an objective before-and-after, and change over time is what most often signals a problem worth evaluating.

Why the urgency around change? Because catching skin cancer early dramatically improves outcomes. Most melanomas are found while still localized, and localized melanoma is highly survivable, whereas melanoma that has spread is far more dangerous 2. Because immunosuppression is a higher-risk situation, a changing spot is better seen within weeks than watched for months.

If something looks suspicious, the next step is an in-person exam and, when warranted, a biopsy, where a small sample is examined under the microscope to make the diagnosis 3. No photo and no description can confirm or rule out cancer on its own. If a biopsy shows cancer, treatment aims to remove it completely, and terms like clear surgical margins describe making sure no cancer is left at the edges.

What the screening evidence does and doesn't say

It helps to separate two different questions. Routine screening asks whether examining healthy, symptom-free people finds enough cancer to be worth it; the US Preventive Services Task Force concluded the current evidence is insufficient to weigh the benefits and harms of routine whole-body skin exams in asymptomatic adults 4. That is a statement about the average-risk general public.

That insufficient-evidence finding is often misread as skin checks not helping. It does not say that. It specifically does not address the individualized surveillance clinicians provide to higher-risk people, and it does not address evaluating a lesion you are worried about, which is a diagnostic question, not screening.

For immunosuppressed patients, the practical answer is the one your care team gives: a monitoring schedule matched to your risk, which the wider guidance on skin check frequency and post-treatment skin cancer surveillance can help you understand. If cost is a barrier between visits, free skin cancer screening events, including AAD SPOTme screening, are one way to get an interim look.

Sun protection between checks

Skin checks find cancer; sun protection helps prevent it, and it matters more when immunosuppression has reduced your skin's own defenses. Ultraviolet radiation from the sun and tanning beds is the main modifiable driver of skin cancer, so cutting that exposure is the highest-yield prevention step between appointments 5. Daily broad-spectrum sunscreen, protective clothing, hats, shade, and avoiding tanning beds are the practical core.

The evidence for daily sunscreen is not just theoretical. In long-term randomized follow-up, adults who used sunscreen regularly developed fewer melanomas than those who used it only sometimes 6. Sunscreen does not undo past sun damage, but it slows new damage on skin that is already working with less immune protection.

Built into a routine, sun protection and regular skin checks reinforce each other: one lowers how many suspicious spots appear, the other makes sure the ones that do are found early.

Common questions

There is no universal number, because it depends on your medicines, how long you have been immunosuppressed, your skin type, and your history of skin cancer. Immunosuppressed people generally need more frequent professional skin exams than the average adult, and the specific schedule is set by your dermatologist or transplant team. Between those visits, a monthly self-check is the standard companion habit.

Both can play a role. A primary care clinician can examine your skin and refer anything concerning, while a dermatologist is trained specifically in evaluating skin lesions and performing biopsies. For higher-risk, immunosuppressed patients, ongoing skin surveillance is often coordinated with a dermatologist. The main thing is that someone is regularly doing a thorough full-skin exam and that you can get seen quickly if a spot changes.

Use the ABCDE signs for moles: asymmetry, irregular borders, more than one color, larger diameter, and especially evolving or changing spots. Beyond moles, watch for any sore that will not heal, a spot that bleeds or itches, or a growth that keeps enlarging. Check low-sun areas too: soles, palms, between the toes, under the nails, and genital skin, which are easy to overlook.

Coverage varies by plan and by whether the visit is framed as screening or as evaluation of a specific problem. For immunosuppressed and transplant patients, medically indicated skin surveillance is more likely to be covered, but it is worth confirming with your plan. If cost is a barrier, community and free skin cancer screening events can provide an interim look between covered visits.

Yes. The goal is sensible sun protection, not avoiding daylight entirely. Daily broad-spectrum sunscreen, protective clothing, a hat, sunglasses, and shade during peak hours let you be outdoors while cutting the ultraviolet dose that drives skin cancer. Reducing that exposure is one of the most useful prevention habits when immunosuppression has lowered your skin's natural defenses.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Spots worth getting checked without delay

  • A mole or spot that is changing in size, shape, or color, or a new pigmented spot, especially between scheduled skin checks
  • A sore, scab, or ulcer that will not heal within a few weeks, or that heals and reopens in the same place
  • A new or enlarging bump that bleeds, crusts, or is tender, on sun-exposed or covered skin
  • A dark streak under a nail, or a new dark spot on a palm, sole, or genital skin

This article is health information, not a diagnosis, and it does not set your personal skin-check schedule — your dermatologist or care team does. No one can tell from a photo or a description whether a spot is cancer; only an in-person exam and, when needed, a biopsy can. Report any changing or non-healing lesion to your clinician.

References

  1. 1.Tsao H, Olazagasti JM, Cordoro KM, et al. (2015). Early detection of melanoma: reviewing the ABCDEs. Journal of the American Academy of Dermatology. PMID 25698455The ABCDE criteria — Asymmetry, Border irregularity, Color variegation, Diameter greater than 6 mm, and Evolving — are clinical features that support early melanoma detection during self and clinician skin examination.
  2. 2.National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025). Cancer Stat Facts: Melanoma of the Skin. NIH / National Cancer Institute (SEER). linkMost melanomas are diagnosed at a localized stage, and localized melanoma has far higher five-year relative survival than melanoma that has spread to distant sites.
  3. 3.Swetter SM, Tsao H, Bichakjian CK, et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2018.08.055A suspicious lesion is diagnosed by biopsy and histopathologic examination; surgical excision aims for clear margins with no tumor at the edges.
  4. 4.US Preventive Services Task Force (2023). Skin Cancer: Screening. US Preventive Services Task Force. linkThe USPSTF found insufficient evidence to weigh the benefits and harms of routine whole-body visual skin-cancer screening in asymptomatic adults; it does not address diagnostic evaluation of concerning lesions or surveillance of higher-risk people.
  5. 5.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Skin Cancer Prevention (PDQ®)–Health Professional Version. NIH / National Cancer Institute. linkUltraviolet radiation from the sun and tanning beds is a modifiable risk factor for skin cancer; reducing UV exposure is a prevention step.
  6. 6.Green AC, Williams GM, Logan V, Strutton GM (2011). Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up. Journal of Clinical Oncology. PMID 21135266In long-term randomized follow-up, adults who used sunscreen regularly developed fewer melanomas than those who used it only occasionally.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy